{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Bush administration said Wednesday that it would monitor the prices of prescription drugs bought by Medicare beneficiaries to ensure they are not overcharged when they start using drug discount cards next June. The discount card program was authorized by the new Medicare law as a temporary measure to help elderly and disabled people until the full-fledged drug benefit becomes available on Jan. 1, 2006.", "headline": {"main": "Medicare to Monitor Prices in New Drug Plan"}, "abstract": "Bush administration says that it will monitor prices of prescription drugs bought by Medicare beneficiaries to ensure they are not overcharged when they start using drug discount cards in June 2004 (M)", "print_page": "38", "word_count": 650, "_id": "4fd231c28eb7c8105d7c13fa", "snippet": "The Bush administration said Wednesday that it would monitor the prices of prescription drugs bought by Medicare beneficiaries to ensure they are not overcharged when they start using drug discount cards next June.    The discount card program was...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/11/us/medicare-to-monitor-prices-in-new-drug-plan.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2003-12-11T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The pharmacy benefit companies that manage drug coverage for most working Americans commonly offer millions of dollars in payments to important customers when contracts with them are signed, according to industry executives and consultants. The practice is receiving widespread attention after Justice Department officials on Tuesday accused Medco Health Solutions, one of the largest pharmacy benefit managers, of violating kickback laws by paying $87.4 million to Oxford Health Plans.", "headline": {"main": "Payments By Managers Of Drug Plans Face Scrutiny"}, "abstract": "Practice by pharmacy benefit companies that manage drug coverage to offer millions of dollars in payments to important customers when contract with them are signed is receiving widespread attention after Justice Department accuses Medco Health Solutions of violating kickback laws by paying $87.4 million to Oxford Health Plans; Medco and Oxford, which received money two years ago, say payments were legal and appropriate; some industry experts say such payments often add to drug costs that pharmacy benefit managers were hired to shrink; Mark Campbell, chief executive of pharmacy benefit manager Innoviant, says it is not uncommon for number of pharmacy benefit managers to offer prospective customers up to $10 per covered person, theoretically to cover transition costs of installing new contract; adds Innoviant does not (M)", "print_page": "3", "word_count": 713, "_id": "4fd235d98eb7c8105d7c7b58", "snippet": "The pharmacy benefit companies that manage drug coverage for most working Americans commonly offer millions of dollars in payments to important customers when contracts with them are signed, according to industry executives and consultants.     The...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/11/business/payments-by-managers-of-drug-plans-face-scrutiny.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CAMPBELL, MARK"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "MEDCO HEALTH SOLUTIONS"}, {"name": "organizations", "value": "OXFORD HEALTH PLANS"}, {"name": "organizations", "value": "INNOVIANT"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2003-12-11T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Neither Mark Rzepka's colleagues nor his competitors were amused when The Winnipeg Free Press published a two-part series recently about the lavish way Mr. Rzepka and his wife had decorated their new 6,800-square-foot house in this prairie city. Mr. Rzepka is a co-founder of Mediplan Health Consulting, the biggest of a number of Canadian Internet drugstores that sell lower-priced prescription drugs to Americans, arousing admiration from some quarters and anger from others.", "headline": {"main": "Pressure on Canada's Online Drug Sellers"}, "abstract": "American and Canadian politicians, regulators and consumers are scrutinizing Canadian online drug sellers that sell lower-priced prescription drugs to Americans; many US state and local politicians have said they favor easier access to cheaper imported drugs for Americans, but major drug makers have lobbied against idea, seeing it as threat to their biggest and most profitable market; new Medicare law legalizes cross-border drug purchases, but only for foreign drugs that secretary of health and human services certifies are safe; any certifications are not likely to happen soon; Canadian International Pharmacy Association executive director David MacKay and Canada-based Mediplan Health Consulting co-founder Mark Rzepka comment; photos (M)", "print_page": "1", "word_count": 1369, "_id": "4fd231b98eb7c8105d7c0e4f", "snippet": "Neither Mark Rzepka's colleagues nor his competitors were amused when The Winnipeg Free Press published a two-part series recently about the lavish way Mr. Rzepka and his wife had decorated their new 6,800-square-foot house in this prairie city.    ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/12/10/business/pressure-on-canada-s-online-drug-sellers.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MACKAY, DAVID"}, {"name": "persons", "value": "RZEPKA, MARK"}, {"name": "glocations", "value": "CANADA"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "MEDIPLAN HEALTH CONSULTING"}, {"name": "organizations", "value": "CANADIAN INTERNATIONAL PHARMACY ASSN"}, {"name": "subject", "value": "SALES"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "COMPUTERS AND THE INTERNET"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bernard", "lastname": "SIMON"}], "original": "By BERNARD SIMON"}, "document_type": "article", "pub_date": "2003-12-10T00:00:00Z", "section_name": "Technology; Health; Business"}], "meta": {"hits": 3, "offset": 0, "time": 24}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}